Abstract
This work reports the synthesis, radiolabeling and preliminary biodistribution results in tumor-bearing mice of [99mTc(CO)3(PA-TZ-CHC)]+. The novel colchicine (CHC) ligand was successfully synthesized via “click” reaction. Radiolabeling was performed in high yield with [99mTc(CO)3]+ core to get [99mTc(CO)3(PA-TZ-CHC)]+, which was hydrophilic and cationic, and was stable at room temperature. Biodistribution studies in tumor-bearing mice showed that [99mTc(CO)3(PA-TZ-CHC)]+ accumulated in the tumor with good uptake while comparatively low retention. The clearance of the 99mTc-complex from normal organs was fast, resulting in increasing tumor/blood and tumor/muscle ratios. The promising results in preliminary biodistribution studies warrant further research to improve tumor targeting efficacy and pharmacokinetic profile of radiolabeled CHC derivative by structural modification.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have